118P Can CD 47 be a targeted treatment in desmoid tumors?
younger age groups having lower hazard ratios.Furthermore, the results showed that Black patients have a higher risk of death, with a hazard ratio of 1.314.Conclusions: There is no significant difference in the survival rates between males and females receiving neoadjuvant therapy, These results highlight the importance of focusing on individual patient characteristics rather than gender alone when devising treatment plans Studies on the role of genetic and molecular markers in predicting patient response to therapy are needed.
Authors
- S. Atas Ipek (ORCID: https://orcid.org/0000-0003-1377-0488)
- Mehmet Mutlu Kıdı (ORCID: https://orcid.org/0000-0002-4750-720X)
- Serhat Yaslıkaya (ORCID: https://orcid.org/0000-0001-9298-7145)
- E. Bayram (ORCID: https://orcid.org/0000-0002-2333-6805)
- T. Koseci
- İsmail Oğuz Kara (ORCID: https://orcid.org/0000-0003-4963-2028)
- Sedat Biter (ORCID: https://orcid.org/0000-0002-1053-0668)
- Yasemin Aydınalp Camadan (ORCID: https://orcid.org/0000-0003-2435-368X)
- Esra Asarkaya
- Hatice ASOĞLU RÜZGAR (ORCID: https://orcid.org/0009-0000-1366-5552)
- Müzeyyen Aslı Ergözoğlu
- M.S. Erayman
Institutions
- Cukurova University (TR)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.104431
- Primary Topic
- Soft tissue tumor case studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00